Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-03 · accession 0001104659-22-056000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-03 | PTGX | Waddill William D. | Dir | M - OptEx | $8.59 | +12.0K | 12.0K | New | +$103.1K |
| D | 2022-05-04 | 2022-05-03 | PTGX | Waddill William D. | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | M | A | 12,000 | $8.59 | 12,000 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-05-03 | M | D | 12,000 | $0.00 | 0 | D | $8.59 · — to 2027-05-25 | 12,000 Common Stock | (F1) The shares subject to this option are vested in full. |